Photrexa cross-linking kit 6ML
Ended Awarded
- Contract number
- SPE2DB25FCMXQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,728
Award facts
- Contract value 100% obligated
- $3,727.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $3,727.51 by the Defense Logistics Agency (DLA) on August 13, 2025. The contract calls for delivery of a Photrexa Cross-Linking Kit (6ml), a specialized pharmaceutical product, with an ultimate completion date of September 4, 2025. This delivery order was issued without a set-aside designation, allowing the vendor to compete directly in the federal procurement marketplace based on its established capabilities and pricing.
This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities worldwide. The IDC encompasses branded and generic prescription drugs, biologics, medical consumables, and specialty medications across multiple product categories. As a key supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently secured delivery orders from the DLA to fulfill critical medical supply needs across military health facilities.
Quick answers
Who was awarded contract SPE2DB25FCMXQ?
SPE2DB25FCMXQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 13, 2025.
How much is contract SPE2DB25FCMXQ worth?
The government has obligated $3,728 on SPE2DB25FCMXQ.
Is contract SPE2DB25FCMXQ an order under another contract?
Yes. SPE2DB25FCMXQ is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMXQ competed?
The extent of competition for SPE2DB25FCMXQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award